Nurses Internal Contamination by Antineoplastic Drugs.

Impact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients with Risk Factors

NCT03257969 ·Status: RECRUITING ·Phase: NA

Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics

NCT02828462 ·Status: UNKNOWN

Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment

NCT04797143 ·Status: RECRUITING

Tolerance of Anti-Cancer Therapy in the Elderly

NCT05251922 ·Status: UNKNOWN

Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy

NCT04327583 ·Status: UNKNOWN ·Phase: NA

Impact of Hospital Pharmacist on Drug Management in Patients With Bronchopulmonary Cancer

NCT06469957 ·Status: COMPLETED

The Perceived Mismatch Between Dose Recommendations of PKI's and the Clinical Practice

NCT06402812 ·Status: COMPLETED

Tc-99m Renography and Cisplatin-induced Nephrotoxicity

NCT00213642 ·Status: TERMINATED

Adherence to Oral Anticancer Treatment Using Electronic Monitoring System

NCT01058044 ·Status: COMPLETED ·Phase: NA

Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2

NCT04142463 ·Status: UNKNOWN ·Phase: NA

Pharmacist-led Intervention on Adherence in Patients Undergoing Treatment With an Oral Oncology Medication

NCT03104114 ·Status: COMPLETED ·Phase: NA

Optimizing the Management of Patients With Oral Therapy

NCT03623490 ·Status: TERMINATED ·Phase: NA

Impact of Clinical Pharmacy Consultations in Patients With Cancer Treated With Oral Anti-cancer Therapies on the Rate of Serious Adverse Events

NCT02733965 ·Status: UNKNOWN ·Phase: NA

Securing and Optimizing the Patient's Drug Therapy With Cancer: Clinical Pharmacy and Articulation With the City

NCT02896478 ·Status: COMPLETED

Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer

NCT00033345 ·Status: COMPLETED ·Phase: PHASE1

Carcinogenicity Study of Bupropion

NCT01077596 ·Status: COMPLETED

Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment

NCT00210249 ·Status: COMPLETED

Knowledge, Attitudes and Practices of Safe Handling of CDs

NCT06857656 ·Status: NOT_YET_RECRUITING

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

NCT06297369 ·Status: RECRUITING ·Phase: PHASE2

A Study of the Absorption, Metabolism, and Excretion of [14C]-Brensocatib Following a Single Oral Administration in Healthy Male Participants

NCT05652257 ·Status: COMPLETED ·Phase: PHASE1

ADOPT-PRESTAGE: Study Evaluating the Impact of the Program PRESTAGE

NCT03296150 ·Status: RECRUITING ·Phase: NA

Effect of Genetic Polymorphism on Capecitabine-Induced Toxicity in Egyptian Cancer Patients

NCT06765252 ·Status: RECRUITING

Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion

NCT00227136 ·Status: TERMINATED ·Phase: PHASE3

Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy

NCT00379665 ·Status: COMPLETED ·Phase: PHASE2

Onco-haematology Vigilance Card

NCT04931329 ·Status: UNKNOWN